Apoptosis Flashcards

1
Q

Describe the roles of apoptosis

A

Harmful cells (e.g. cells with viral infection, DNA damage).

  1. Developmentally defective cells (e.g. B lymphocytes expressing antibodies against self antigens).- lack of self tolerance
  2. Excess / unnecessary cells:- important in morphogenesis
    (embryonic development: brain to eliminate excess neurons; liver regeneration; sculpting of digits and organs).
  3. Obsolete cells (e.g. mammary epithelium at the end of lactation).- involution- returns to its dormant state
  4. Exploitation - Chemotherapeutic killing of cells.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What technique can be used to detect dying, apoptotic cells

A

The TUNEL technique

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define necrosis

A

Necrosis - unregulated cell death associated with trauma, cellular disruption and an inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define apoptosis

A

Apoptosis (programmed cell death) - regulated cell death; controlled disassembly of cellular contents without disruption; no inflammatory response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is important to remember about the different types of cell death

A

There is a spectrum- and some types have characteristics of both necrosis and apoptosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline the process of necrosis

A

Plasma membrane becomes permeable

Cell swelling and rupture of cellular membranes

Release of proteases leading to autodigestion and dissolution of the cell- everything becomes dysregulates as the cell contents are no longer contained within the plasma membrane.

Localised inflammation

Basically the cell explodes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe what happens upon trauma to the cell in necrosis

A

Trauma to the intestinal epithelium:
Cells and organelles swell
Chromatin condenses
Membrane compromised- fluid rushes in

Dissolution of cellular structures (proteases)
Cell lysis (fluid rushing in)
Invasion from phagocytic cells and inflammation
Proliferation of neighbouring cells to restore the integrity of the epithelium.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the latent phase of apoptosis

A

Latent phase – death pathways are activated, but cells
appear morphologically the same
Changes are at a molecular level- the cell’s programming is getting ready to apoptose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the excitation phase of apoptosis

A

Loss of microvilli and intercellular junctions (so impermeability of the cell is compromised)
Cell shrinkage (unlike the swelling of necrosis).
Loss of plasma membrane asymmetry
(phosphatidylserine lipid appears in outer leaflet)
Chromatin and nuclear condensation
DNA fragmentation
Formation of membrane blebs
Fragmentation into membrane-enclosed apoptotic
bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the charge of phosphatidylserine

A

Negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a key feature of apoptosis that distinguishes it from necrosis

A

Plasma membrane remains intact – no inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Outline the process of apoptosis

A

Faulty mitosis/excessive DNA damage- usually localised to one cell:
Latent phase
Microvilli contract
intercellular junctions break (impermeability compromised)
Chromatin begins to condense
Cell shrinks- neighbouring cells close around to restore impermeability
Chromatin condenses around nuclear periphery
cell blebs violently
chromatin condensation continunes
cell fragments into membrane-enclosed apoptotic bodies
apoptotic cell bodies phagoyctosed by neighbouring cells and roving macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the DNA modifications that occur during apoptosis

A

DNA ladders – fragmentation
(agarose gel)- DNA initially intact- too big to fit into channels- but as it condenses- we see fragmentations on the DNA ladder

“TUNEL” assay
DNA fragmentation leads to more “ends” which are labelled by adding an extra fluorescently-tagged base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe apoptosis like-PCD

A

Apoptosis-like PCD - some, but not all, features of apoptosis. Display of phagocytic recognition molecules before plasma membrane lysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe necrosis like-PCD

A

Necrosis-like PCD - Variable features of apoptosis before cell lysis; “Aborted apoptosis”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does the fact that there are other types of cell death (other than necrosis and apoptosis) suggest

A

o The fact that these other forms exist suggests a GRADED response of cell death.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Summarise the mechanisms of apoptotic cell death

A

o Caspase cascade – the executioners.

o Death response – death receptors and mitochondria- sequential activation of proteins to drive intracellular response

o Bcl-2 family -regulators

o Stopping the death programme.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are caspases

A

Cysteine-dependent aspartate-directed proteases (so their cleavage site is between cysteine and aspartame)

Executioners of apoptosis

Activated by proteolysis (secreted as dimers or auto-folded- need to be cleaved by another protease to activate their

Cascade of activation- need both an initiator and effector capsase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

State the initiator caspases

A

2,9,10 and 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

State the effector caspases

A

3,6 and 7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Describe the structure of initiator caspases

A

§ 2 subunits – p20 and P10 (P20 is larger)

§ They have an extra targeting subunit:

· CARD – Caspase Recruitment Domain ( 2 and 9)

· DED – Death Effector Domain ( 10 and 8)

o These direct them to a location.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the structure of effector caspases

A

P20 and P10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are the key differences between initiator caspases and effector caspases

A

Initiator caspases: contain N-terminal CARD (CAspase Recruitment Domain) or DED (Death Effector Domain) for homotypic protein-protein interactions (i.e caspase 8 can only interact with caspase 8)

Effector caspases do not contain protein-protein interaction domains.

o Initiator caspases – 2, 9, 8, 10 – TRIGGER APOPTOSIS.
o Effector caspases – 3, 6, 7 – CARRY OUT APOPTOSIS PROCESS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What structures do caspases recognise

A

o A cysteine residue in the active site is required for their activity.

o They cut proteins after their aspartate residue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Describe the synthesis and maturation of caspases

A

Synthesises as procaspases (zymogens)- inactive
These contain pro-domains at their N-terminal (DED or CARD if initiator) which undergo proteolytic cleavage (either by themselves or another caspase)
They then dimerise with another caspases (e.g caspase 3 and 8) to form a hetero-tetramer
Cleavage of the small chain
Cleavage of the inactive procaspase precursor is followed by folding of 2 large and 2 small chains to form an active L2S2 heterotetramer (this synchronises the two caspases for subsequent steps)

26
Q

Outline the caspase cascade

A

Initiator caspases (8 and 9) – trigger apoptosis by cleaving and activating..

Activate caspase 3 and 7:
Caspase 3 can then activate 6,2, and 1
6 can activate 10- which has a feedback loop on 8

…Effector caspases – carry out the apoptotic programme

27
Q

Describe the importance of the caspase cascade

A

amplification
divergent responses (different initiator caspases can activate different effector caspases)
regulation

28
Q

Describe the role of effector caspases in inactivating proteins

A

Cleave and inactivate proteins or complexes (e.g. nuclear lamins leading to nuclear breakdown)

Can cleave and inactivate monomeric substrates or multi protein complexes (nuclear lamins)

These lead to loss of function of the substrates

29
Q

Describe the roles of effector caspases in activating proteins

A

Activate enzymes
(incl. protein kinases; nucleases, e.g. Caspase-Activated DNase, CAD) by direct cleavage, or
cleavage of inhibitory
molecules

Again can be monomeric substrates or multi protein complexes
This leads to a gain of function of the substrates

30
Q

Outline the two mechanisms for caspase activation

A

Death by design – Receptor-mediated (extrinsic) pathways- senses something extracellularly

Death by default – Mitochondrial (intrinsic) death pathway

31
Q

What are death receptors

A
Secreted or transmembrane ligands (trimeric)- so need 3 to join for activation
Include:
TNFR1
Fas
DR3
DR4
DR5
DR6
NGFR

Adapter proteins can bind to the cytoplasmic tails of death receptors- to bring them to the procaspases

32
Q

Describe the structure of death receptors

A

All cells have death receptors which consist of:

o Extracellular cysteine domains (N-terminal -cysteine rich)

o Transmembrane domain.

o Cytoplasmic tail – death domain (C-terminal)- important in transmitting the signal into the cell

33
Q

Describe the adapter proteins involved in receptor-mediated apoptosis

A

§ FADD – positive regulator – promotes cell death.

o FADD = DED + DD.

§ FLIP – negative regulator – inhibits the death pathway and allows regulation.

o FLIP = DED + DED.

34
Q

Describe DD and DED domains

A

DD and DED domains bind to similar domains on other proteins- i.e DED on FADD will bind to DED on procaspases

35
Q

Describe signalling through the extrinsic pathway

A
  1. Fas receptor is upregulated when the cell needs to apoptose (i.e on infected cells)
  2. Fas ligand on cytotoxic T-cells binds to the Fas receptor and Fas receptor trimerises.
  3. Trimerised DD domains recruit adaptor proteins such as FADD (via the DD domains on FADD)
  4. FADD binding causes recruitment and oligomerisation (links monomers to form dimers/trimers/etc.) of procaspase 8 through DED à FADD DED.
  5. Procaspase 8 + FADD à DISC (Death-inducing-signalling-complex).
  6. DISC cross-activates other procaspase 8 molecules.
  7. Active caspase 8 is released to cleave effector caspases.
36
Q

Describe the importance of oligomerisation of procaspase 8 in the extrinsic pathway

A

Some initiator procaspases have intrinsic low catalytic activity – oligomerisation allows transcleavage
others are activated by conformational change on oligomerisation
Need at least 2 procaspases to form an active tetramer

DD cleaved- 2 of these join with internal domains to form active tetramer

37
Q

Describe FLIP

A

Death Receptor activation of caspase 8 is inhibited by FLIP
c-FLIPs -only DED domains
c-FLIPl- DED domains and P20, P10
FLIP - caspase homology in DED domain, but no proteolytic activity therefore competes with procaspase -so binds to the DED domain of FADD- but prevents oligomerisation

38
Q

Describe how FLIP inhibits procaspase 8 inactivation

A

Competes for binding to receptor tails / FADD via DED domains
Incorporates into receptor-procaspase complexes and interferes with transcleavage
Hence no formation of active tetramer- no activation of effector caspases.

39
Q

What are the consequences of caspase 8 activation

A

Active caspase 8 can then go on to activate the other effector caspases that then carry out the apoptotic process.
Acticates caspase 3 and 7

40
Q

Outline the mitochondrial regulation of apoptosis (intrinsic pathway)

A

Cellular stresses e.g. lack of or overstimulation by growth factors, DNA damage (p53), ROS
This leads to a loss of mitochondrial membrane potential
So you get release of cytochrome c and other intracellular mitochondrial factors- including apoptosis-promoting factors (Apaf1, caspase 9)
Formation of the apoptosome complex (Apaf1, caspase 9)

41
Q

What does the apoptosome consist of

A

§ The Apoptosome – “The Wheel of Death” – consists of:

o APAF-1 – Apoptotic Factor 1.

o Cytochrome C.

o ATP.

o Procaspase 9.

42
Q

Describe the formation of the apoptosome

A

§ APAF1 is composed of CARD, ATPase and WD-40 repeats.

§ When cytochrome C binds to WD-40 repeats on APAF-1, it forms a heptamer (the apoptosome) which requires ATP.

§ The CARD domain then binds to CARD on procaspase 9 (so seven procaspases can bind to one apoptosome).

§ Proximity of procaspases then allows cross-cleaving.

§ Activated caspase 9 is then released to trigger apoptosis.

43
Q

Describe the activation of Caspase 9 at the apoptosome

A

Caspase-9: attach to any of the Apaf-1 CARD domains at the centre of the ring in a dimer with caspase-3


- oligomerisation brings multiple procaspase 9s close together- can dimerise or trimerise

  • cleavage, activation and release as active caspase 9 tetramer initiates a caspase cascade leading to apoptosis

activated caspase 9s can then go on to activate effector caspases, such as caspase 3

44
Q

Describe how apoptosis requires energy

A

The apoptosome requires ATP
Energy levels in the cell may determine whether
death is by necrosis or apoptosis- not enough ATP will mean that the cell dies by necrosis.

45
Q

Which pro-apoptotic protein links the intrinsic pathway to the extrinsic pathway

A

Bid
Caspase 8 cleaves Bid which enhances release of mitochondrial proteins (CytC), thus engaging the intrinsic pathway
§ Major difference – intrinsic mitochondrial pathway requires energy (ATP).

o Apoptosis always uses intrinsic to some degree so will always use ATP.

§ Remember that necrosis uses MUCH LESS ATP

46
Q

Which family of proteins act as regulators of the intrinsic pathway

A

The Bcl-2 family
The large family of Bcl-2 family proteins can be pro-apoptotic or anti-apoptotic. Their only common feature is the presence of so-called BH3 protein-protein interaction domains that mediate binding between different members of the family.

47
Q

Describe the Bcl-2 family of proteins

A

Group (1)- Bcl-2 -consist of a transmembrane domain, and four Bcl-2 homologous domains (BH1-4)
Groups 2 (Bax)- transmembrane domains and BH1-3
Group (3):
Bid- only BH3, not bound to mitochondrial membrane
Bik,Bad- TM domain and BH3

BH3 is the dimerisation motif

48
Q

State the anti-apoptotic Bcl-2 proteins

A

Anti-apoptotic

   Bcl-2
   Bcl-xL

(Mitochondrial)

49
Q

State the pro-apoptotic Bcl-2 family of proteins

A

Pro-apoptotic

   Bid
   Bad
   Bax
   Bak

(move between Cytosol and Mitochondria)

50
Q

What two signalling pathways can GFs activate to stimulate growth and anti-apoptotic effects

A

§ GFs (EGF, insulin) may activate TWO growth factor pathways associated with anti-apoptotic effects.

§ Ligand binds à dimerisation à cross-phosphorylation à signal transduction and docking of adapter proteins (e.g. Grb2) to adapt pathway direction (e.g. activating Ras à MAPK/ERK cascade)- leading to growth

§ Another phosphorylation site on tyrosine kinase receptors triggers the PI3-kinase pathway à cell survival and anti-apoptotic effects.

51
Q

Outline the PI3-kinase pathway

A

PI3-K– PDK-1 — PKB/Akt — Survival, proliferation

52
Q

What is PI3-K

A

Phosphatidylinositol 3’-kinase (PI3’-K) – a lipid kinase (not a protein kinase) involved in growth control and cell survival
Activates protein kinase PKB/Akt which is anti-apoptotic

Consists of 3 subunits:
o Targeting subunit.

o Adapter subunit.

o Catalytic subunit.

53
Q

Describe the PI3-K signalling pathway

A
Adapter subunit (P85) of PI3-K binds to phosphorylating tyrosine residue
Targeting subunit (P110) of PI3-K recognises PIP2 and phosphorylates it (requiring ATP) to PIP3
PIP3 then sits on PH domain of mitochondrial membrane- where it recruits PKB/Akt- which is anti-apoptotic.
54
Q

What are the roles of PKB/Akt

A

Phosphorylates and inactivates Bad

Phosphorylates and inactivates caspase 9

Inactivates FOXO transcription factors (FOXOs promote expression of apoptosis-promoting genes)

Other, e.g. stimulates ribosome production and protein synthesis

Induce cell survival by blocking apoptosis.

55
Q

Describe how the PKB/Akt (PI3’-K, GF pathways) lead to cell-survival

A

Activation of PKB/Akt will lead to the phosphorylation of Bad- allowing it to be held in an inactive heterodimer with protein 14-3-3.
As Bad is not free it means that the inactive mitochondrial membrane heterodimers of Bcl-2-Bax and Bcl-xL- Bak remain inactive (joined via their BH3 domains)
So as the heterodimers are inactive and phsphobad is inactive we get cell survival.

56
Q

Describe how the absence of growth factor will lead to apoptosis

A

Bad dephosphorylated and released
displaces Bcl-2/-xL from -> Bax/Bak (pro-apoptotic)
§ Bcl-2 family proteins (Bax, Bak) then form a pore in the mitochondrial membrane to allow cytochrome C to escape to induce apoptosis.

57
Q

What are the end results of the PKB/Akt pathways

A

Cell survival

Protein synthesis

58
Q

What is the role of PTEN

A

PTEN (lipid phosphatase) counteracts PI3’-K signalling
Removes a phosphate from PIP3 to form PIP2
· Counteracts the activation of PKB

· Reduces cell survival and promotes apoptosis

59
Q

What is the role of the inhibitors of apoptosis proteins (IAPs)

A

Extrinsic pathway
Bind to procaspases and prevent activation

Bind to active caspases and inhibit their activity

60
Q

Outline the apoptotic/cyto-protective pathways

A

Bcl-2, Bcl-xL: intrinsic pathway

FLIP, IAPs: extrinsic pathway

growth factor pathways via PI3’-K and PKB/Akt

61
Q

Summarise the oncogenes/TSGs associated with apoptosis

A

§ Bcl-2 Oncogene – as overexpression of Bcl-2 results in cancer.

§ PKB/Akt Oncogene – as overexpression of PKB leads to increased cell survival and thus cancer.

§ PTEN TSG – as inactivation raises the PI3-K pathway and thus allows increased survival of cancer.

62
Q

Summarise the Therapeutic uses of apoptosis

A

Harmful (oncogenic) cells (e.g. cells with viral infection, DNA damage)

Chemotherapeutic killing of tumour cells, e.g. Dexamethasone stimulates DNA cleavage- therefore stimulating apoptosis.